Analysis of US Food and Drug Administration Breast Implant Postapproval Studies Finding an Increased Risk of Diseases and Cancer: Why the Conclusions Are Unreliable
- PMID: 30730863
- PMCID: PMC6392206
- DOI: 10.1097/SAP.0000000000001732
Analysis of US Food and Drug Administration Breast Implant Postapproval Studies Finding an Increased Risk of Diseases and Cancer: Why the Conclusions Are Unreliable
Conflict of interest statement
Conflicts of interest and sources of funding: none declared. E.S. receives royalties from Springer Nature (Cham, Switzerland). The author received no financial support for the research, authorship, and publication of this article.
Comment on
-
US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients.Ann Surg. 2019 Jan;269(1):30-36. doi: 10.1097/SLA.0000000000002990. Ann Surg. 2019. PMID: 30222598
References
-
- Coroneos CJ, Selber JC, Offodile AC, 2nd, et al. US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg. 2019;269:30–36. - PubMed
-
- Allergan. Post-approval studies (PAS). November 6, 2017. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_i.... Accessed September 25, 2018.
-
- Mentor Corp. Post-Approval Studies (PAS). November 6, 2017. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_i.... Accessed September 25, 2018.
-
- Karlson EW, Lee IM, Cook NR, et al. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women's Health Cohort Study. Am J Epidemiol. 1999;150:652–660. - PubMed
-
- Sackett DL, Straus SE, Richardson WS, et al. Therapy. In: Evidence-Based Medicine. 2nd ed Toronto, ON, Canada: Churchill Livingstone; 2000:105–154.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical